Brief: Exact Therapeutics Announces Positive Clinical Results From ACTIVATE Phase I Dose Escalation
26/09/2023 07:39
Sept 26 (Reuters) - Exact Therapeutics AS EXTX.OL :
* EXACT THERAPEUTICS ANNOUNCES POSITIVE CLINICAL RESULTS
FROM THE
ACTIVATE PHASE I DOSE ESCALATION
* POSITIVE SAFETY AND ANTICANCER ACTIVITY RESULTS FROM DOSE
ESCALATION PART OF ACTIVATE TRIAL
Source text for Eikon: ID:nObiwwZ73a
Further company coverage: EXTX.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Exact Therapeutics AS
See all newsBrief: EXACT Therapeutics AS Gets Positive Safety Review For 60 Μl/Kg Dose In Phase 2 ENACT Trial
Brief: Exact Therapeutics Introduces New Long-Term Incentive Program
Brief: Exact Therapeutics H1 Operating Loss Widens To NOK 45.9 Million
Brief: Exact Therapeutics Announces Grant Of Core Patent In U.S.
Brief: Exact Therapeutics Announces Final Positive Data From Phase 1 Trial